Back to Journals » OncoTargets and Therapy » Volume 12

Ultra-Low-Dose Bevacizumab For Cerebral Radiation Necrosis: A Prospective Phase II Clinical Study

Total article views   HTML views PDF downloads Totals
7,822 Dovepress* 6,695+ 688 7,383
PubMed Central* 1,127 285 1,412
Totals 7,822 973 8,795
*Since 11 October 2019

View citations on PubMed Central and Google Scholar